{"id":15027,"date":"2022-04-25T13:13:51","date_gmt":"2022-04-25T11:13:51","guid":{"rendered":"https:\/\/ggba.swiss\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/"},"modified":"2023-07-04T13:40:32","modified_gmt":"2023-07-04T11:40:32","slug":"vaud-based-imaging-specialist-nanolive-raises-usd-20-million","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/","title":{"rendered":"Vaud-based cell imaging specialist Nanolive raises USD 20 million"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.nanolive.ch\/\" target=\"_blank\" rel=\"noopener\">Nanolive<\/a>\u2019s cutting edge label-free microscope devices and state-of-the-art digital analytical solutions provide researchers and scientists working in the biopharmaceutical industry and laboratories with all the tools required to accelerate innovation in growth industries such as drug discovery and cell therapy.<\/p>\n<p>Being able to screen thousands of living cells in 3D, without damaging them promises to radically advance how scientists study living cells. Moreover, the quantitative analytical suite the Vaud-based scale-up offers is a complete game-changer.<\/p>\n<p>Combining sub-cellular resolution with unique AI-assisted digital assays provide researchers and scientists a unique opportunity to study complex cell-drug perturbation dynamics and cell-cell interactions (e.g., T cell and target cell interactions), quantitatively, an approach that will revolutionize the cell-based assay phase of the drug discovery workflow.<\/p>\n<p>Nanolive\u2019s USD 20 million Series C-1 equity financing round was led by a US-based and NASDAQ listed life science investor, and <a href=\"https:\/\/en.taiwaniacapital.com\/\" target=\"_blank\" rel=\"noopener\">Taiwania Capital<\/a>, a leading life science venture capital company based in Taiwan. The round of investment was also supported by existing investors, including <a href=\"https:\/\/ventures.swisscom.com\/\" target=\"_blank\" rel=\"noopener\">Swisscom Ventures<\/a>, along with other partners.<\/p>\n<h4>Transforming the discovery and development of therapteutics<\/h4>\n<p>\u201cLife Sciences are undergoing a fundamental transformation, and Nanolive is at the heart of it,\u201d said Dr. Yann Cotte, CEO and Co-Founder of Nanolive. \u201cWe are honored to receive an investment from such an impressive group of investors who are excited to support us in our goal to transform the discovery and development of therapeutics. With this fundraising, we believe Nanolive is well positioned to drive significant growth of our Digital Assay solutions and is at the leading edge of this global bioeconomy gold rush. We are selling the best picks and shovels for live cell solutions.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A leader in the field of live cell imaging and analysis, Nanolive has successfully completed its first financing round in the amount of USD 20 million.<\/p>\n","protected":false},"author":3,"featured_media":15028,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[912,926,911],"class_list":["post-15027","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-biotech","tag-medtech","tag-pharma"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vaud-based cell imaging specialist Nanolive raises USD 20 million - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaud-based cell imaging specialist Nanolive raises USD 20 million - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"A leader in the field of live cell imaging and analysis, Nanolive has successfully completed its first financing round in the amount of USD 20 million.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-25T11:13:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:40:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Vaud-based cell imaging specialist Nanolive raises USD 20 million\",\"datePublished\":\"2022-04-25T11:13:51+00:00\",\"dateModified\":\"2023-07-04T11:40:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/\"},\"wordCount\":285,\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg\",\"keywords\":[\"Biotech\",\"Medtech\",\"Pharma\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/\",\"name\":\"Vaud-based cell imaging specialist Nanolive raises USD 20 million - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg\",\"datePublished\":\"2022-04-25T11:13:51+00:00\",\"dateModified\":\"2023-07-04T11:40:32+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaud-based cell imaging specialist Nanolive raises USD 20 million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaud-based cell imaging specialist Nanolive raises USD 20 million - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/","og_locale":"en_US","og_type":"article","og_title":"Vaud-based cell imaging specialist Nanolive raises USD 20 million - Greater Geneva Bern area","og_description":"A leader in the field of live cell imaging and analysis, Nanolive has successfully completed its first financing round in the amount of USD 20 million.","og_url":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2022-04-25T11:13:51+00:00","article_modified_time":"2023-07-04T11:40:32+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mathieu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#article","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Vaud-based cell imaging specialist Nanolive raises USD 20 million","datePublished":"2022-04-25T11:13:51+00:00","dateModified":"2023-07-04T11:40:32+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/"},"wordCount":285,"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg","keywords":["Biotech","Medtech","Pharma"],"articleSection":["Life sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/","url":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/","name":"Vaud-based cell imaging specialist Nanolive raises USD 20 million - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#primaryimage"},"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg","datePublished":"2022-04-25T11:13:51+00:00","dateModified":"2023-07-04T11:40:32+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/NanoLive-20-million-630x380-1-3.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/staging.ggba.swiss\/en\/vaud-based-imaging-specialist-nanolive-raises-usd-20-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Vaud-based cell imaging specialist Nanolive raises USD 20 million"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/en\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/15027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=15027"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/15027\/revisions"}],"predecessor-version":[{"id":17128,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/15027\/revisions\/17128"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/15028"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=15027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=15027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=15027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}